{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:18:48Z","timestamp":1776485928563,"version":"3.51.2"},"reference-count":62,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010450","name":"Ministry of Higher Education and Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010450","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.humimm.2018.02.012","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T07:51:09Z","timestamp":1519977069000},"page":"463-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Clinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma"],"prefix":"10.1016","volume":"79","author":[{"given":"Wafa","family":"Babay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Ben Yahia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Boujelbene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nour","family":"Zidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Baligh","family":"Laaribi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhikra","family":"Kacem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radhia","family":"Ben Ghorbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdellatif","family":"Boudabous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadda-Imene","family":"Ouzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Rebmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karima","family":"Mrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00e8s","family":"Zidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.humimm.2018.02.012_b0005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0923-2494(96)89643-X","article-title":"Antigen-presenting function(s) of the non-classical HLA-E, -F and -G class I molecules: the beginning of a story","volume":"147","author":"Le Bouteiller","year":"1996","journal-title":"Res. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2018.02.012_b0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0198-8859(90)90076-2","article-title":"Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissue","volume":"29","author":"Wei","year":"1990","journal-title":"Hum. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2018.02.012_b0015","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0092-8674(81)90318-4","article-title":"Major histocompatibility antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules","volume":"24","author":"Ploegh","year":"1981","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.humimm.2018.02.012_b0020","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.4049\/jimmunol.171.3.1376","article-title":"Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition","volume":"171","author":"Ishitani","year":"2003","journal-title":"J. Immunol."},{"issue":"4952","key":"10.1016\/j.humimm.2018.02.012_b0025","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1126\/science.2326636","article-title":"A class I antigen, HLA-G, expressed in human trophoblasts","volume":"248","author":"Kovats","year":"1990","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.humimm.2018.02.012_b0030","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M","article-title":"HLA-E is expressed on trophoblast and interacts with CD94\/NKG2 receptors on decidual NK cells","volume":"30","author":"King","year":"2000","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2018.02.012_b0035","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.humimm.2006.12.003","article-title":"Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections","volume":"68","author":"Megret","year":"2007","journal-title":"Hum. Immunol."},{"issue":"10","key":"10.1016\/j.humimm.2018.02.012_b0040","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s00262-004-0517-9","article-title":"The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape","volume":"53","author":"Algarra","year":"2004","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.humimm.2018.02.012_b0045","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.semcancer.2007.07.005","article-title":"Immune-refractory cancers and their little helpers \u2013 an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?","volume":"17","author":"Wischhusen","year":"2007","journal-title":"Semin. Cancer Biol."},{"issue":"7","key":"10.1016\/j.humimm.2018.02.012_b0050","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/00000478-200207000-00010","article-title":"HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis","volume":"26","author":"Singer","year":"2002","journal-title":"Am. J. Surg. Pathol."},{"issue":"15","key":"10.1016\/j.humimm.2018.02.012_b0055","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1073\/pnas.1431057100","article-title":"Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G","volume":"100","author":"Shiroishi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.humimm.2018.02.012_b0060","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1074-7613(00)80529-4","article-title":"A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules","volume":"7","author":"Cosman","year":"1997","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.humimm.2018.02.012_b0065","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.4049\/jimmunol.164.12.6100","article-title":"Cutting edge: soluble HLA-G1 triggers CD95\/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8","volume":"164","author":"Fournel","year":"2000","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.humimm.2018.02.012_b0070","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1182\/blood-2005-12-019919","article-title":"Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells","volume":"108","author":"Fons","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humimm.2018.02.012_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humimm.2004.10.006","article-title":"HLA-E surface expression is independent of the availability of HLA class I signal sequence-derived peptides in human tumor cell lines","volume":"66","author":"Palmisano","year":"2005","journal-title":"Hum. Immunol."},{"issue":"26","key":"10.1016\/j.humimm.2018.02.012_b0080","doi-asserted-by":"crossref","first-page":"10656","DOI":"10.1073\/pnas.1100354108","article-title":"HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8(+) T lymphocytes","volume":"108","author":"Gooden","year":"2011","journal-title":"PNAS"},{"issue":"5","key":"10.1016\/j.humimm.2018.02.012_b0085","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1084\/jem.187.5.813","article-title":"Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94\/NKG2 confers protection from natural killer cell-mediated lysis","volume":"187","author":"Borrego","year":"1998","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.humimm.2018.02.012_b0090","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W","article-title":"HLA-E-bound peptides influence recognition by inhibitory and triggering CD94\/NKG2 receptors: preferential response to an HLA-G-derived nonamer","volume":"28","author":"Llano","year":"1998","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2018.02.012_b0095","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4049\/jimmunol.162.1.305","article-title":"Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94\/NKG2A and NK cells","volume":"162","author":"Brooks","year":"1999","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.humimm.2018.02.012_b0100","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1158\/0008-5472.CAN-04-2108","article-title":"Up-regulation of inhibitory natural killer receptors CD94\/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma","volume":"65","author":"Sheu","year":"2005","journal-title":"Cancer Res."},{"issue":"6669","key":"10.1016\/j.humimm.2018.02.012_b0105","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.humimm.2018.02.012_b0110","first-page":"307","article-title":"WHO classification of tumours of female reproductive organs","volume":"6","author":"Kurman","year":"2014","journal-title":"WHO Press"},{"issue":"1","key":"10.1016\/j.humimm.2018.02.012_b0115","first-page":"9","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.humimm.2018.02.012_b0120","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.2006.07.9970","article-title":"Early events in the pathogenesis of epithelial ovarian cancer","volume":"26","author":"Landen","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.humimm.2018.02.012_b0125","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/ijc.20649","article-title":"Ovarian cancer in Europe: cross-sectional trends in incidence and mortality in 28 countries, 1953\u20132000","volume":"113","author":"Bray","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.humimm.2018.02.012_b0130","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.semcancer.2007.06.012","article-title":"Clinical and biological significance of HLA-G expression in ovarian cancer","volume":"17","author":"Sheu","year":"2007","journal-title":"Semin. Cancer Biol."},{"issue":"10","key":"10.1016\/j.humimm.2018.02.012_b0135","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2217\/fon.09.126","article-title":"Pathogenesis of ovarian cancer: clues from selected overexpressed genes","volume":"5","author":"Shih","year":"2009","journal-title":"Fut. Oncol."},{"issue":"5","key":"10.1016\/j.humimm.2018.02.012_b0140","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.humimm.2018.02.012_b0145","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","article-title":"Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma","volume":"95","author":"Singer","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.humimm.2018.02.012_b0150","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1525-1438.2007.01039.x","article-title":"Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance","volume":"18","author":"Salani","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.humimm.2018.02.012_b0155","doi-asserted-by":"crossref","first-page":"274584","DOI":"10.1155\/2014\/274584","article-title":"HLA-G expression is an independent predictor for improved survival in high grade ovarian carcinomas","volume":"2014","author":"Rutten","year":"2014","journal-title":"J. Immunol. Res."},{"issue":"12","key":"10.1016\/j.humimm.2018.02.012_b0160","first-page":"4460","article-title":"HLA-G is a potential tumor marker in malignant ascites","volume":"9","author":"Singer","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.humimm.2018.02.012_b0165","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.humimm.2007.01.010","article-title":"Application of human leukocyte antigen\u2013G expression in the diagnosis of human cancer","volume":"68","author":"Shih","year":"2007","journal-title":"Hum. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2018.02.012_b0170","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/cas.12641","article-title":"Human leukocyte antigen-E alleles and expression in patients with serous ovarian cancer","volume":"106","author":"Zheng","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.humimm.2018.02.012_b0175","unstructured":"[Guildeline] J. Prat, FIGO committee on gynecologic oncology. FIGO Staging classification for cancer of ovary, fallopain tube, and peritoneum, Int. J. Gynecol. Obstet. 124(1) (2014) 1\u20135."},{"issue":"4","key":"10.1016\/j.humimm.2018.02.012_b0180","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.humimm.2012.11.021","article-title":"Multiple steps of HLA-G in ovarian carcinoma metastasis: alter NK cytotoxicity and induce matrix metalloproteinase-15 (MMP-15) expression","volume":"74","author":"Lin","year":"2013","journal-title":"Hum. Immunol."},{"issue":"58","key":"10.1016\/j.humimm.2018.02.012_b0185","article-title":"HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma","volume":"7","author":"Kren","year":"2012","journal-title":"Diagn. Pathol."},{"issue":"1","key":"10.1016\/j.humimm.2018.02.012_b0190","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ygyno.2004.09.049","article-title":"HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma","volume":"96","author":"Davidson","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.humimm.2018.02.012_b0195","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1440-1789.2010.01149.x","article-title":"Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: an unexpected prognostic significance?","volume":"31","author":"Kren","year":"2011","journal-title":"Neuropathology"},{"issue":"10","key":"10.1016\/j.humimm.2018.02.012_b0200","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1245\/s10434-007-9464-y","article-title":"Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma","volume":"14","author":"Yie","year":"2007","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.humimm.2018.02.012_b0205","doi-asserted-by":"crossref","first-page":"891","DOI":"10.7150\/ijbs.4383","article-title":"Expression of human leukocyte antigen G is associated with prognosis in nasopharyngeal carcinoma","volume":"8","author":"Cai","year":"2012","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.humimm.2018.02.012_b0210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ygyno.2006.01.045","article-title":"Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma","volume":"103","author":"Barrier","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.humimm.2018.02.012_b0215","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00251-002-0526-9","article-title":"Analysis of HLA-E expression in human tumors","volume":"54","author":"Mar\u00edn","year":"2003","journal-title":"Immunogenetics"},{"issue":"3","key":"10.1016\/j.humimm.2018.02.012_b0220","first-page":"349","article-title":"Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells","volume":"2","author":"Fukushima","year":"1998","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.humimm.2018.02.012_b0225","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0065-2776(03)81006-4","article-title":"HLA-G molecules: from maternal-fetal tolerance to tissue acceptance","volume":"81","author":"Carosella","year":"2003","journal-title":"Adv. Immunol."},{"issue":"11","key":"10.1016\/j.humimm.2018.02.012_b0230","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1093\/annonc\/mdm356","article-title":"HLA-G expression in human ovarian carcinoma counteracts NK cell function","volume":"18","author":"Lin","year":"2007","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.humimm.2018.02.012_b0235","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1182\/blood.V99.2.609","article-title":"HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas","volume":"99","author":"Urosevic","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humimm.2018.02.012_b0240","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/ijc.26375","article-title":"HLA-G expression is associated with metastasis and poor survival in the Balb\/c nu\/nu murine tumor model with ovarian cancer","volume":"131","author":"Lin","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.humimm.2018.02.012_b0245","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2018.02.012_b0250","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1440-1827.2009.02369.x","article-title":"Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors","volume":"59","author":"Kawamura","year":"2009","journal-title":"Pathol. Int."},{"issue":"3","key":"10.1016\/j.humimm.2018.02.012_b0255","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1084\/jem.20111413","article-title":"Ovarian cancer progression is controlled by phenotypic changes in dendritic cells","volume":"209","author":"Scarlett","year":"2012","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.humimm.2018.02.012_b0260","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1177\/1933719109342131","article-title":"Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer","volume":"16","author":"Jung","year":"2009","journal-title":"Reprod. Sci."},{"issue":"7","key":"10.1016\/j.humimm.2018.02.012_b0265","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1182\/blood-2006-06-030213","article-title":"Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation","volume":"109","author":"Coupel","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humimm.2018.02.012_b0270","doi-asserted-by":"crossref","first-page":"e1052213","DOI":"10.1080\/2162402X.2015.1052213","article-title":"Non-classical HLA-class I expression in serous ovarian carcinoma: correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis","volume":"5","author":"Andersson","year":"2016","journal-title":"Oncoimmunology"},{"issue":"12","key":"10.1016\/j.humimm.2018.02.012_b0275","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.humimm.2009.07.021","article-title":"Human leukocyte antigen-G is expressed in advanced-stage ovarian carcinoma of high-grade histology","volume":"70","author":"Menier","year":"2009","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2018.02.012_b0280","article-title":"Lesion HLA-G5\/-G6 isoforms expression in patients with ovarian cancer","author":"Zhang","year":"2015","journal-title":"Hum. Immunol."},{"issue":"9","key":"10.1016\/j.humimm.2018.02.012_b0285","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1593\/neo.101684","article-title":"Human leukocyte antigen E contributes to protect tumor cells from lysis by natural killer cells","volume":"13","author":"Monaco","year":"2011","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.humimm.2018.02.012_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humimm.2004.10.006","article-title":"HLA-E surface expression is independent of the availability of HLA class I signal sequence-derived peptides in human tumor cell lines","volume":"66","author":"Palmisano","year":"2005","journal-title":"Hum. Immunol."},{"issue":"10","key":"10.1016\/j.humimm.2018.02.012_b0295","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI0215564","article-title":"IFN-\u03b3 protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94\/NKG2A-dependent mechanism","volume":"110","author":"Malmberg","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.humimm.2018.02.012_b0300","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00428-005-0144-7","article-title":"Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma","volume":"449","author":"Kleinberg","year":"2006","journal-title":"Virchows Arch."},{"issue":"12","key":"10.1016\/j.humimm.2018.02.012_b0305","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.4049\/jimmunol.1002629","article-title":"HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients","volume":"185","author":"de Kruijf","year":"2010","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2018.02.012_b0310","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/bjc.2013.696","article-title":"Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients","volume":"110","author":"Zeestraten","year":"2014","journal-title":"Br. J. Cancer"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885918300508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885918300508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:50:50Z","timestamp":1759319450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885918300508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0198885918300508"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2018.02.012","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2018.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}